You have 9 free searches left this month | to do more
Showing 1 - 25 of
365 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
    Sant P Chawla
2021-09-09
Sep 9, 2021
U
Recruiting
  • Classical Hodgkin Lymphoma
  • Dacarbazine
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-10
Mar 10, 2022
P
Recruiting
  • Leiomyosarcoma
  • Jacksonville, Florida
  • +4 more
2022-03-14
Mar 14, 2022
S
Recruiting
  • LMS - Leiomyosarcoma
  • Uterine Leiomyosarcoma
  • Stanford, California
    Stanford University
2022-02-11
Feb 11, 2022
N
Completed
  • Malignant Melanoma
  • Recurrent Melanoma
  • Dacarbazine
  • +2 more
  • (no location specified)
2020-10-18
Oct 18, 2020
N
Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
2021-05-14
May 14, 2021
U
Active, not recruiting
  • Metastatic Melanoma
  • Proleukin and Dacarbazine
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
M
Completed
  • Melanoma
  • PI-88 and dacarbazine
  • dacarbazine or DTIC
  • Tucson, Arizona
  • +11 more
2020-12-29
Dec 29, 2020
P
Not yet recruiting
  • Leiomyosarcoma
  • (no location specified)
2022-02-25
Feb 25, 2022
I
Recruiting
  • Solitary Fibrous Tumors
  • Prato, Firenze, Italy
  • +5 more
2021-10-29
Oct 29, 2021
C
Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
2022-03-17
Mar 17, 2022
S
Recruiting
  • Metastatic Melanoma
  • Unresectable Melanoma
  • JS001 240mg Q2W
  • Dacarbazine 1000mg/m2 Q3W
  • Beijing, Beijing, China
  • +2 more
2020-09-28
Sep 28, 2020
U
Recruiting
  • Immunotherapy
  • Dacarbazine (DTIC)
  • Erlangen, Bavaria, Germany
    University Hospital
2021-01-13
Jan 13, 2021
F
Terminated
  • Hodgkin Lymphoma
  • Houston, Texas
  • +10 more
2021-08-18
Aug 18, 2021
C
Completed
  • Stage IV Melanoma
  • recombinant interferon alfa-2b
  • +4 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Ce
2020-07-22
Jul 22, 2020
S
Recruiting
  • Hodgkin Lymphoma, Adult
  • Moscow, Russian Federation
    The Federal Budget-Funded Institution National Medical Surgical
2020-11-20
Nov 20, 2020
U
Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Cologne, Germany
    University Hospital of Cologne
2021-04-06
Apr 6, 2021
N
Terminated
  • Melanoma
  • St. Petersburg, Russian Federation
  • +2 more
2019-11-22
Nov 22, 2019
P
Recruiting
  • Soft Tissue Sarcoma
  • Dacarbazine
  • onfekafusp alfa
  • Münster, Germany
    Münster University Hospital
2022-03-16
Mar 16, 2022
B
Completed
  • Melanoma
  • BMS-936558 (Nivolumab)
  • +3 more
  • Capital Federal, Buenos Aires, Argentina
  • +74 more
2021-08-02
Aug 2, 2021
U
Not yet recruiting
  • Hodgkin Lymphoma
  • Involved site radiotherapy
  • +6 more
  • (no location specified)
2021-09-27
Sep 27, 2021
O
Recruiting
  • Melanoma (Skin)
  • OrienX010 injection
  • Dacarbazine (DTIC)
  • Beijing, Beijing, China
    Beijing Cancer Hospital
2020-02-25
Feb 25, 2020